Fetal hydrops – a review and a clinical approach to identifying the cause

IF 0.8 4区 医学 Q4 PHARMACOLOGY & PHARMACY Expert Opinion on Orphan Drugs Pub Date : 2020-02-13 DOI:10.1080/21678707.2020.1719827
E. Dempsey, T. Homfray, J. Simpson, S. Jeffery, S. Mansour, P. Ostergaard
{"title":"Fetal hydrops – a review and a clinical approach to identifying the cause","authors":"E. Dempsey, T. Homfray, J. Simpson, S. Jeffery, S. Mansour, P. Ostergaard","doi":"10.1080/21678707.2020.1719827","DOIUrl":null,"url":null,"abstract":"ABSTRACT Introduction: Fetal hydrops describes abnormal fluid accumulation in two or more extravascular fetal compartments. It is a poor prognostic sign in a fetus, and many will not survive to term. Fetal hydrops is a clinical sign rather than a diagnosis and has a multitude of different causes. Areas covered: This review focusses on nonimmune fetal hydrops. We discuss in detail the most common etiologies such as infection and chromosomal abnormalities and cover rarer presentations of congenital malformation and single-gene disorders. We present a decision tree for the investigation of affected pregnancies. Expert opinion: The current approach to the investigation of fetal hydrops largely revolves around identifying the abnormal pathophysiology via ultrasound imaging. We believe that as genomic testing of a pregnancy can be undertaken with increasing accuracy, speed, accessibility and at reduced cost, genetic testing will feature earlier in the future diagnostic pathway.","PeriodicalId":12118,"journal":{"name":"Expert Opinion on Orphan Drugs","volume":"8 1","pages":"51 - 66"},"PeriodicalIF":0.8000,"publicationDate":"2020-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21678707.2020.1719827","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Orphan Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21678707.2020.1719827","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 7

Abstract

ABSTRACT Introduction: Fetal hydrops describes abnormal fluid accumulation in two or more extravascular fetal compartments. It is a poor prognostic sign in a fetus, and many will not survive to term. Fetal hydrops is a clinical sign rather than a diagnosis and has a multitude of different causes. Areas covered: This review focusses on nonimmune fetal hydrops. We discuss in detail the most common etiologies such as infection and chromosomal abnormalities and cover rarer presentations of congenital malformation and single-gene disorders. We present a decision tree for the investigation of affected pregnancies. Expert opinion: The current approach to the investigation of fetal hydrops largely revolves around identifying the abnormal pathophysiology via ultrasound imaging. We believe that as genomic testing of a pregnancy can be undertaken with increasing accuracy, speed, accessibility and at reduced cost, genetic testing will feature earlier in the future diagnostic pathway.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胎儿水肿——一项综述和确定病因的临床方法
摘要简介:胎儿水肿是指两个或多个血管外胎儿腔室的异常液体积聚。这对胎儿来说是一个不良的预后迹象,许多胎儿无法存活到足月。胎儿水肿是一种临床症状,而不是一种诊断,有多种不同的原因。涵盖领域:本综述的重点是非免疫性胎儿水肿。我们详细讨论了最常见的病因,如感染和染色体异常,并涵盖了先天性畸形和单基因疾病的罕见表现。我们提出了一个决策树的调查影响怀孕。专家意见:目前研究胎儿水肿的方法主要是通过超声成像来识别异常的病理生理。我们相信,随着妊娠基因组检测的准确性、速度、可及性和成本的提高,基因检测将在未来的诊断途径中占据更早的地位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Opinion on Orphan Drugs
Expert Opinion on Orphan Drugs PHARMACOLOGY & PHARMACY-
CiteScore
2.30
自引率
0.00%
发文量
8
期刊介绍: Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs.
期刊最新文献
Emerging therapies against Naegleria fowleri Current and emerging therapies for the treatment of leishmaniasis The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022 Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing Overview of genetic testing in Prader-willi syndrome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1